Last reviewed · How we verify
Standard Allergic Rhinitis Treatment
At a glance
| Generic name | Standard Allergic Rhinitis Treatment |
|---|---|
| Sponsor | Tanta University |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- A Study of Lebrikizumab in Adult Participants With Perennial Allergic Rhinitis (PREPARED-1) (PHASE3)
- Allergic Rhinitis Improvement Through Strategic Education: The ARISE Trial (NA)
- INTRANASAL FLUTICASONE VERSUS FLUTICASONE-AZELASTINE COMBINATION (PHASE4)
- Harnessing Digital Medicine to Improve Allergic Rhinitis Management in Primary Care (DMAR) (NA)
- The Effect of Apple Fruit Extract (Malus Sylvestris Mill) as an Antioxidant and Anti-Inflammatory on Allergic Rhinitis (NA)
- Study of CM310 in Patients With Uncontrolled Seasonal Allergic Rhinitis (PHASE2)
- Effect of Combined Probiotics and Vitamin D on Symptoms of Allergic Rhinitis (NA)
- Combination of Oral Supplement With Fatty Acids, Vitamin B6, Perilla, and Liquorice With Nasal Steroids for the Treatment of Allergic Rhinitis (EARLY_PHASE1)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Standard Allergic Rhinitis Treatment CI brief — competitive landscape report
- Standard Allergic Rhinitis Treatment updates RSS · CI watch RSS
- Tanta University portfolio CI